De Quervain's thyroiditis medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
{{CMG}} {{MMF}} | {{CMG}} {{MMF}} | ||
==Overview== | ==Overview== | ||
The mainstay of therapy for de Quervain's thyroiditis is aspirin or non-steroidal anti-inflammatory drugs for pain control. Beta-adrenergic blockers are recommended for the patients who develop thyrotoxic symptoms. | The mainstay of therapy for de Quervain's thyroiditis is aspirin or non-steroidal anti-inflammatory drugs for pain control. Beta-adrenergic blockers are recommended for the patients who develop thyrotoxic symptoms. | ||
==Medical Therapy== | ==Medical Therapy== | ||
The drugs used in the treatment of De Quervain's thyroiditis are:<ref name="pmid20886353">{{cite journal |vauthors=Engkakul P, Mahachoklertwattana P, Poomthavorn P |title=Eponym : de Quervain thyroiditis |journal=Eur. J. Pediatr. |volume=170 |issue=4 |pages=427–31 |year=2011 |pmid=20886353 |doi=10.1007/s00431-010-1306-4 |url=}}</ref><ref name="pmid3427792">{{cite journal |vauthors=Yamamoto M, Saito S, Sakurada T, Fukazawa H, Yoshida K, Kaise K, Kaise N, Nomura T, Itagaki Y, Yonemitsu K |title=Effect of prednisolone and salicylate on serum thyroglobulin level in patients with subacute thyroiditis |journal=Clin. Endocrinol. (Oxf) |volume=27 |issue=3 |pages=339–44 |year=1987 |pmid=3427792 |doi= |url=}}</ref> | The drugs used in the treatment of De Quervain's thyroiditis are:<ref name="pmid20886353">{{cite journal |vauthors=Engkakul P, Mahachoklertwattana P, Poomthavorn P |title=Eponym : de Quervain thyroiditis |journal=Eur. J. Pediatr. |volume=170 |issue=4 |pages=427–31 |year=2011 |pmid=20886353 |doi=10.1007/s00431-010-1306-4 |url=}}</ref><ref name="pmid3427792">{{cite journal |vauthors=Yamamoto M, Saito S, Sakurada T, Fukazawa H, Yoshida K, Kaise K, Kaise N, Nomura T, Itagaki Y, Yonemitsu K |title=Effect of prednisolone and salicylate on serum thyroglobulin level in patients with subacute thyroiditis |journal=Clin. Endocrinol. (Oxf) |volume=27 |issue=3 |pages=339–44 |year=1987 |pmid=3427792 |doi= |url=}}</ref> | ||
| Line 13: | Line 12: | ||
#Corticosteroids | #Corticosteroids | ||
#*Corticosteroids usually show a dramatic response in severely ill patients within 24-48 hours. | #*Corticosteroids usually show a dramatic response in severely ill patients within 24-48 hours. | ||
Drug Regimen: | Drug Regimen: | ||
Corticosteroids 40 mg of prednisone daily | |||
*[[Levothyroxine (oral)|Synthetic levothyroxine]] (L-T4) 1.6–1.8 μg/kg of body weight per day orally. | *[[Levothyroxine (oral)|Synthetic levothyroxine]] (L-T4) 1.6–1.8 μg/kg of body weight per day orally. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 16:28, 1 August 2017
|
De Quervain's thyroiditis Microchapters |
|
Differentiating De Quervain's thyroiditis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Furqan M M. M.B.B.S[2]
Overview
The mainstay of therapy for de Quervain's thyroiditis is aspirin or non-steroidal anti-inflammatory drugs for pain control. Beta-adrenergic blockers are recommended for the patients who develop thyrotoxic symptoms.
Medical Therapy
The drugs used in the treatment of De Quervain's thyroiditis are:[1][2]
- Asprin or NSAIDs
- Aspirin and non-steroidal anti-inflammatory drugs are used for pain control.
- Beta adrenergic blockers
- Beta-adrenergic blockers such as propranolol and atenolol are used for controlling thyrotoxic symptoms.
- Corticosteroids
- Corticosteroids usually show a dramatic response in severely ill patients within 24-48 hours.
Drug Regimen: Corticosteroids 40 mg of prednisone daily
- Synthetic levothyroxine (L-T4) 1.6–1.8 μg/kg of body weight per day orally.
References
- ↑ Engkakul P, Mahachoklertwattana P, Poomthavorn P (2011). "Eponym : de Quervain thyroiditis". Eur. J. Pediatr. 170 (4): 427–31. doi:10.1007/s00431-010-1306-4. PMID 20886353.
- ↑ Yamamoto M, Saito S, Sakurada T, Fukazawa H, Yoshida K, Kaise K, Kaise N, Nomura T, Itagaki Y, Yonemitsu K (1987). "Effect of prednisolone and salicylate on serum thyroglobulin level in patients with subacute thyroiditis". Clin. Endocrinol. (Oxf). 27 (3): 339–44. PMID 3427792.